http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220080057041%22.PGNR.&OS=DN/20080057041&RS=DN/20080057041
"Derivation of embryonic stem cells and embryo-derived cells"
Abstract
This present invention provides novel methods for deriving embryonic stem cells and embryo-derived cells from an embryo without requiring destruction of the embryo. The invention further provides cells and cell lines derived without embryo destruction, and the use of the cells for therapeutic and research purposes. It also relates to novel methods of establishing and storing an autologous stem cell line prior to implantation of an embryo, e.g., in conjunction with reproductive therapies such as IVF.
more facts
strong proof that ACTC is on the move!!!!
With this Patent there is NO Destruction of the embryo!
The application is the patent.
Read the application as the wording and technical discovery for the patent will be the same!
http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220080057041%22.PGNR.&OS=DN/20080057041&RS=DN/20080057041
So it could be next week?
Highlight these words from that quote, "without requiring destruction of the embryo. The invention further provides cells and cell lines derived without embryo destruction"...that is a big deal.
good find...
Looks like ACTC should get their patent published by the end of January 2011. Based on where they are at in the process it takes on average 6 weeks to get approved/published.
It is already a done deal as the application 20080057041 no longer shows up on ACTs current application list.
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=0&p=1&f=S&l=50&Query=%22Advanced+Cell+Technology%22&d=PG01
IMO this ACT's US patent application 20080057041 becoming a US Patent is what brought about the ACT-Roslin JV!